Mansel-Jones D, Taylor T, Doyle E, Chasseaud L F, Darragh A, O'Kelly D A, Over H
J Clin Pharmacol. 1978 Nov-Dec;18(11-12):544-8. doi: 10.1002/j.1552-4604.1978.tb01583.x.
After application of 100 mg (nominal dose) isosorbide dinitrate as an ointment to the skin of human subjects, mean drug concentrations were 1 to 2 ng/ml for 1.5 hour and reached a peak of 6.2 ng/ml at 6 hours. Thereafter, mean concentrations declined slowly to 2.9 ng/ml at 12 hours and 1.2 ng/ml at 24 hours. After a sublingual dose of 5 mg isosorbide dinitrate, mean drug concentrations reached a peak of 15.9 ng/ml at 0.5 hour and declined with a half-life of about 50 minutes. The mean bioavailability of isosorbide dinitrate from the ointment was estimated as 30 per cent of that from the sublingual tablet when corrected for differences in dose/body weight ratio. The results demonstrate that concentrations of isosorbide dinitrate in plasma can be maintained for relatively long periods when the drug is applied to the skin.
将100毫克(标称剂量)硝酸异山梨酯软膏涂抹于人体受试者皮肤后,药物平均浓度在1.5小时内为1至2纳克/毫升,6小时时达到峰值6.2纳克/毫升。此后,平均浓度缓慢下降,12小时时降至2.9纳克/毫升,24小时时降至1.2纳克/毫升。舌下含服5毫克硝酸异山梨酯后,药物平均浓度在0.5小时时达到峰值15.9纳克/毫升,并以约50分钟的半衰期下降。校正剂量/体重比差异后,硝酸异山梨酯软膏的平均生物利用度估计为舌下片剂的30%。结果表明,当将该药物涂抹于皮肤时,血浆中硝酸异山梨酯的浓度可维持较长时间。